These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9551143)

  • 21. [p53 mutations and their role in tumorigenesis].
    Tsuchida N; Munirajan AK
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1567-75. PubMed ID: 9279083
    [No Abstract]   [Full Text] [Related]  

  • 22. Conquering the complexity of p53.
    Attardi LD; DePinho RA
    Nat Genet; 2004 Jan; 36(1):7-8. PubMed ID: 14702030
    [No Abstract]   [Full Text] [Related]  

  • 23. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
    Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
    Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
    Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wild-type p53 demonstrates functional dominance in a human colon carcinoma cell line in which it induces reversible growth arrest.
    Yang B; Stambrook PJ; Markowitz SD
    Clin Cancer Res; 1996 Oct; 2(10):1639-47. PubMed ID: 9816111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of p53 gene mutations in breast cancers and their effects on transcriptional activation function.
    Oh SJ; Jung JY; Shim SS; Im MY; Kim HD; Chung SY; Yoon JH
    Mol Cells; 2000 Jun; 10(3):275-80. PubMed ID: 10901165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest.
    Stavridi ES; Chehab NH; Malikzay A; Halazonetis TD
    Cancer Res; 2001 Oct; 61(19):7030-3. PubMed ID: 11585729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
    Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
    Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
    Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
    Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Checking on the cell cycle.
    Mercer WE
    J Cell Biochem Suppl; 1998; 30-31():50-4. PubMed ID: 9893255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
    Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The p53 tumour suppressor gene.
    Steele RJ; Thompson AM; Hall PA; Lane DP
    Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
    Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
    Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
    Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
    Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p53 tumour suppressor gene and human cancer.
    Roychoudhary G; Mittra I
    Natl Med J India; 1994; 7(3):106-8. PubMed ID: 8069198
    [No Abstract]   [Full Text] [Related]  

  • 39. p53: a cell cycle regulator activated by DNA damage.
    Selivanova G; Wiman KG
    Adv Cancer Res; 1995; 66():143-80. PubMed ID: 7793313
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple roles of the tumor suppressor p53.
    Bargonetti J; Manfredi JJ
    Curr Opin Oncol; 2002 Jan; 14(1):86-91. PubMed ID: 11790986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.